Hologic News

They currently have a $24.00 price target on the stock, down from their previous price target of $26.00. Several other analysts have also recently commented on the stock.

Hologic , a manufacturer of diagnostics products, medical imaging systems and surgical products has appointed Scott T. Garrett to the Company's newly expanded board of directors.

I have no qualms with those who believe it is the responsibility of the management of public companies to communicate clearly and accurately with investors about the current state of the business and the likely near-term conditions.

The firm currently has a "buy" rating on the stock. A number of other firms have also recently commented on HOLX.

Good day, everyone, and welcome to the Hologic Inc. Second Quarter Fiscal 2013 Earnings Conference Call.

Hologic updated its FY13 earnings guidance on Monday. The company provided earnings per share guidance of $1.54-1.56 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.58, AnalystRatingsNetwork.com reports.

Hologic announced its earnings results on Monday. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.34 by $0.01, Stock Ratings Network reports.